Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTo meet the requirements for Mounjaro in the UK, you generally need a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition such as high blood pressure, type 2 diabetes or high cholesterol. A prescriber reviews your full health picture before any treatment is approved. Mounjaro (tirzepatide) is a prescription-only medicine, so clinical assessment isn't a formality — it's the legal and clinical gateway to treatment. The NHS overview of tirzepatide sets out who the medicine is licensed for and what to expect from it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Maybe your GP mentioned tirzepatide but didn't take it further. Maybe you've seen the headlines, done the sums, and are trying to work out whether you'd actually be considered. That's exactly the right place to start — and the criteria are more straightforward than many people expect.
The UK licence for Mounjaro covers adults with a BMI of 30 or above, or a BMI between 27 and 29.9 where at least one weight-related condition is present. That condition list includes type 2 diabetes, prediabetes, high blood pressure, dyslipidaemia (raised cholesterol or triglycerides), obstructive sleep apnoea and osteoarthritis, among others. If you're unsure how your BMI sits, the NHS BMI calculator gives an immediate answer.
BMI thresholds aren't one-size-fits-all. For people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds, UK clinical guidance applies thresholds 2.5 kg/m² lower, so a BMI of 27.5 rather than 30, for instance. A prescriber applies whichever threshold is correct for you. Our detailed page on Mounjaro BMI requirements explains exactly how these adjustments work in practice.
Meeting the BMI requirement is the start of the picture, not the whole of it. A prescriber also reviews your medical history, any medicines you currently take, and whether there are conditions that would mean Mounjaro isn't suitable for you right now. That review matters, and it's why this is a prescription medicine.
Certain conditions don't automatically rule Mounjaro out, but they do require careful discussion. A personal or family history of medullary thyroid carcinoma, or a condition called MEN2 (multiple endocrine neoplasia type 2), means Mounjaro is contraindicated. A history of pancreatitis is another area where a prescriber will want to go carefully, the MHRA has highlighted pancreatitis as a known, if infrequent, risk with GLP-1 medicines, and that context matters when assessing someone with a prior episode.
Kidney and liver function, your current medication list, and any history of gallbladder problems are all part of a thorough assessment. If you take other medicines, our page on taking other medicines alongside Mounjaro covers how interactions are approached.
Mounjaro is not licensed or recommended during pregnancy, while breastfeeding, or for anyone actively trying to conceive. It is not prescribed to under-18s. These are firm lines rather than areas for individual negotiation with a prescriber.
If you have type 2 diabetes, Mounjaro also holds a separate licence for blood-glucose management, so meeting the Mounjaro A1C requirements as a diabetic patient involves a slightly different clinical conversation. Our guide to Mounjaro A1C requirements unpacks that in full.
A point that causes genuine confusion: the requirements for Mounjaro on the NHS are considerably stricter than the licensed eligibility for private prescription. NICE's appraisal of tirzepatide (TA1026) sets out a phased NHS rollout, currently, NHS access requires a BMI of 40 or above alongside four or more specific weight-related conditions. That cohort has gradually widened since June 2025, and a second phase (BMI 35–39.9 with four or more conditions) began in June 2026.
Private prescription, by contrast, follows the licensed indication: BMI 30 or above, or 27 or above with a qualifying condition. There's no waiting list and no referral required, though clinical assessment is just as rigorous. If you're wondering whether the NHS route is open to you, our full breakdown of Mounjaro requirements covers NHS and private pathways side by side.
One practical note: if you're planning to start in the new year and want to time things around a quiet patch at work, it's worth knowing that orders placed before 12pm on a working day are dispatched the same day once clinically approved, so even a Monday order after a bank holiday is straightforward. Our Mounjaro pricing page has a clear breakdown of what private treatment costs.
At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not automated screening. They check your BMI against the UK requirements for Mounjaro, review your health history, confirm your identity and weight (via a brief video check), and consider anything in your profile that needs a closer look before approving treatment.
If you're transferring from another provider, or you've already been on treatment and want to step up a dose, that evidence is reviewed too. Our eligibility guide walks through the questions our prescribers use to assess suitability. And if you want to read about the clinical team overseeing prescribing, our clinical team page has the details.
If you meet the requirements and treatment is approved, your prescription is dispensed from our GPhC-registered pharmacy (registration number 9012878, verifiable at the GPhC register) and sent out via tracked DPD delivery the same day, in plain packaging.
If you'd like a prescriber to assess whether you meet the Mounjaro UK BMI requirements and the wider eligibility criteria, speak to our prescribers through a free consultation, no commitment, no upfront fee.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.